Clinical management of coronavirus disease 2019 (COVID-19) in pregnancy: recommendations of WAPM-World Association of Perinatal Medicine.
Antiviral Agents
/ therapeutic use
Betacoronavirus
Breast Feeding
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
/ methods
Coronavirus Infections
/ complications
Delivery, Obstetric
/ methods
Female
Humans
Immunoglobulin G
/ blood
Immunoglobulin M
/ blood
Infant, Newborn
Infectious Disease Transmission, Vertical
/ statistics & numerical data
Pandemics
Perinatal Care
/ methods
Perinatal Death
Pneumonia, Viral
/ complications
Pregnancy
Pregnancy Complications, Infectious
/ therapy
Reverse Transcriptase Polymerase Chain Reaction
SARS-CoV-2
Stillbirth
/ epidemiology
coronavirus 2019
infection
maternal mortality
pregnancy
Journal
Journal of perinatal medicine
ISSN: 1619-3997
Titre abrégé: J Perinat Med
Pays: Germany
ID NLM: 0361031
Informations de publication
Date de publication:
26 Nov 2020
26 Nov 2020
Historique:
received:
10
06
2020
accepted:
11
06
2020
pubmed:
22
7
2020
medline:
21
11
2020
entrez:
22
7
2020
Statut:
ppublish
Résumé
These guidelines follow the mission of the World Association of Perinatal Medicine, which brings together groups and individuals throughout the world with the goal of improving outcomes of maternal, fetal and neonatal (perinatal) patients. Guidelines for auditing, evaluation, and clinical care in perinatal medicine enable physicians diagnose, treat and follow-up of COVID-19-exposed pregnant women. These guidelines are based on quality evidence in the peer review literature as well as the experience of perinatal expert throughout the world. Physicians are advised to apply these guidelines to the local realities which they face. We plan to update these guidelines as new evidence become available.
Identifiants
pubmed: 32692708
doi: 10.1515/jpm-2020-0265
pii: jpm-2020-0265
doi:
Substances chimiques
Antiviral Agents
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
857-866Références
Spinato, G, Fabbris, C, Polesel, J, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020. https://doi.org/10.1001/jama.2020.6771. Published online April 22, 2020.
Wang, D, Hu, B, Hu, C, Zhu, F, Liu, X, Zhang, J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China. JAMA 2020;323:1061–1069. https://doi.org/10.1001/jama.2020.1585.
Breslin, N, Baptiste, C, Gyamfi-Bannerman, C, et al. COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2020;2:100118. https://doi.org/10.1016/j.ajogmf.2020.100118. [published online ahead of print, 2020 Apr 9].
American College of Radiology. ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection. www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection [Accessed 5 Apr 2020].
Salehi, S, Abedi, A, Balakrishnan, S, Gholamrezanezh. Coronavirus Disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. Am J Roentgenol 14 March 2020;214:1–7. https://doi.org/10.2214/AJR.20.23034 ISSN 0361-803XPMID 32174129.
Lee, EYP, Ng, M-Y, Khong, P-L. COVID-19 pneumonia: what has CT taught us?. Lancet Infect Dis 2020;20:384–385. https://doi.org/10.1016/S1473-3099(20)30134-1.
McCollough, CH, Schueler, BA, Atwell, TD, et al. Radiation exposure and pregnancy: when should we be concerned? Radiographics 2007;27:909–17. https://doi.org/10.1148/rg.274065149 Discussion 917–908.
Wagner, L, Applegate, K. ACR practice guideline for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation. Reston, VA, USA: American College of Radiology; 2008:p. 1–15. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/Pregnant-Pts.pdf?la=en.
Lippi, G, Simundic, A, Plebani, M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clinical Chemistry and Laboratory Medicine (CCLM); 2020. Ahead of Publication https://doi.org/10.1515/cclm-2020-0285 Published online: 16 Mar 2020.
Tahamtana, A, Ardebilib, A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn 2020;20:453–454. https://doi.org/10.1080/147371591-.2020.1757437 Published online: 2020 Apr.
Abbasi, J. The promise and peril of antibody testing for COVID-19. Medical News & Perspectives. JAMA 2020;323:1881–3. April 17, 2020. https://doi.org/10.1001/jama.2020.6170.
Dong, Y, Mo, X, Hu, Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020;145:e20200702. https://doi.org/10.1542/peds.2020-070212.
Breslin, N, Baptiste, C, Gyamfi-Bannerman, C, et al. COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM 2020:100118. https://doi.org/10.1016/j.ajogmf.2020.100118 [published online ahead of print, 2020 Apr 9].
Sutton, D, Fuchs, K, D’Alton, M, Goffman, D. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med 2020; 382:2163–2164. https://doi.org/10.1056/NEJMc2009316 [published online ahead of print, 2020 Apr 13].
Di Mascio, D, Sen, C, Saccone, G, Galindo, A, Grünebaum, A, et al. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus Disease 2019 (COVID-19): analysis of the WAPM study on COVID-19 (in press).
Wu, Z, McGoogan, JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–1242. https://doi.org/10.1001/jama.2020.2648 [published online ahead of print, 2020 Feb 24].
Harris, JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA 1919;72:978–80. https://doi.org/10.1001/Jama.1919.02610140008002.
Freeman, DW, Barno, A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959;78:1172–5. https://doi.org/10.1016/0002-9378(59)90570-8.
Callaghan, WM, Creanga, AA, Jamieson, DJ. Pregnancy-related mortality resulting from influenza in the united states during the 2009–2010 pandemic. Obstet Gynecol 2015;126:486–90. https://doi.org/10.1097/AOG.0000000000000996.
Wong, SF, Chow, KM, Leung, TN, Ng, WF, Ng, TK, Shek, CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004 Jul;191:292–7. https://doi.org/10.1016/j.ajog.2003.11.019.
Alfaraj, SH, Al-Tawfiq, JA, Memish, ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature. J Microbiol Immunol Infect 2019;52:501–3. https://doi.org/10.1016/j.jmii.2018.04.005.
Chen, H, Guo, J, Wang, C, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] [published correction appears in Lancet. 2020 Mar 28;395(10229):1038]. Lancet 2020;395:809–15. https://doi.org/10.1016/S0140-6736(20)303603.
Della Gatta, AN, Rizzo, R, Pilu, G, Simonazzi, G. Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol 2020;S0002-9378:30438–5. https://doi.org/10.1016/j.ajog.2020.04.013 [published online ahead of print, 2020 Apr 18].
Yan, J, Guo, J, Fan, C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol 2020. https://doi.org/10.1016/j.ajog.2020.04.014.
Zaigham, M, Andersson, O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand 2020. https://doi.org/10.1111/aogs.13867 [published online ahead of print, 2020 Apr 7].
Hantoushzadeh, S, Shamshirsaz, AA, Aleyasin, A, et al. Maternal death due to COVID-19 disease. Am J Obstet Gynecol 2020;S0002-9378:30516-0. [published online ahead of print, 2020 Apr 28]. https://doi.org/10.1016/j.ajog.2020.04.030.
Schwartz, DA, Graham, AL. Potential maternal and infant outcomes from (Wuhan) Coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020;12:194. Published 2020 Feb 10. https://doi.org/10.3390/v12020194.
Rasmussen, SA, Jamieson, DJ, Uyeki, TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 2012;207:S3–S8. https://doi.org/10.1016/j.ajog.2012.06.068.
Moretti, ME, Bar-Oz, B, Fried, S, Koren, G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology 2005;16:216–9. https://doi.org/10.1097/01.ede.0000152903.55579.15.
Chen, S, Huang, B, Luo, DJ, et al. Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis of three cases. Zhonghua Bing Li Xue Za Zhi 2020;49:418–23. https://doi.org/10.3760/cma.j.cn112151-20200225-00138.
Ng, WF, Wong, SF, Lam, A, et al. The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation. Pathology 2006;38:210–8. https://doi.org/10.1080/00313020600696280.
Di Mascio, D, Khalil, A, Saccone, G, et al. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020:100107. https://doi.org/10.1016/j.ajogmf.2020.100107 [published online ahead of print, 2020 Mar 25].
Qiu, L, Liu, X, Xiao, M, Xie, J, Cao, W, Liu, Z, et al. SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection. Clin Infect Dis 2020;ciaa375.
Zeng, L, Xia, S, Yuan, W, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 2020. https://doi.org/10.1001/jamapediatrics.2020.0878. Published online March 26, 2020.
Dong, L, Tian, J, He, S, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA 2020;323:1846–8. https://doi.org/10.1001/jama.2020.4621.
Zeng, H, Xu, C, Fan, J, Tang, Y, Deng, Q, Zhang, W, et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA 2020;323:1848–1849.
Hosier, H, Farhadian, S, Morotti, R, et al. SARS-CoV-2 infection of the placenta. medRxiv 2020. https://doi.org/10.1101/2020.04.30.20083907.
Penfield, CA, Brubaker, SG, Limaye, MA, et al. Detection of SARS-COV-2 in placental and fetal membrane samples. Am J Obstet Gynecol MFM 2020:100133. https://doi.org/10.1016/j.ajogmf.2020.100133 [published online ahead of print, 2020 May 8].
Palatnik, A, McIntosh JJ. Protecting labor and delivery personnel from COVID-19 during the second stage of labor. Am J Perinatol 2020. https://doi.org/10.1055/s-0040-1709689. April 10.
COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. National Institutes of Health. Available from: https://www.covid19treatmentguidelines.nih.gov/ [Accessed 1 June 2010].
Clowse, ME, Magder, L, Witter, F, Petri, M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006;54:3640–7. https://doi.org/10.1002/art.22159.
Food and Drug Administration. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems; 2020. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or [Accessed 8 May 2020].
Liu, X, Wang, XJ. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. J Genet Genom 2020;47:119–21. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32173287.
Chen, F, Chan, KH, Jiang, Y, et al. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. J Clin Virol 2004;31:69–75. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15288617.
Dong, L, et al. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 2020;14:58. https://doi.org/10.5582/ddt.2020.01012.
Chen, C, Zhang, Y, Huang, J, Yin, P, Cheng, Z, Wu, J, et al. Favipiravir versus Arbidol for COVID-19: a randomized clinical trial. medRxiv 2020;03. https://doi.org/10.1101/2020.03.17.20037432.